<?xml version="1.0" encoding="UTF-8"?>
<list>
  <sentences>
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2407-2-9.anc" start="14667" end="14672" sStart="-1" offset="0" sid="null" wn="2" wnkey="write%2:32:00::" annotator="tofox" text="LDC &lt;b&gt;wrote&lt;/b&gt; and performed all statistical analysis and preparation of the data presented in this manuscript." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2407-2-9.anc" start="14484" end="14491" sStart="null" offset="0" sid="null" wn="2" wnkey="write%2:32:00::" annotator="tofox" text="The manuscript was prepared and &lt;b&gt;written&lt;/b&gt; by SKT and AWB." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2407-2-9.anc" start="14667" end="14672" sStart="null" offset="0" sid="null" wn="1 10" wnkey="null" annotator="carichter" text="LDC &lt;b&gt;wrote&lt;/b&gt; and performed all statistical analysis and preparation of the data presented in this manuscript." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2407-2-9.anc" start="14667" end="14672" sStart="null" offset="0" sid="null" wn="1" wnkey="write%2:36:00::" annotator="carichter" text="LDC &lt;b&gt;wrote&lt;/b&gt; and performed all statistical analysis and preparation of the data presented in this manuscript." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2407-2-9.anc" start="14540" end="14544" sStart="null" offset="0" sid="null" wn="1" wnkey="read%2:31:00::" annotator="cgozo" text="The manuscript was then &lt;b&gt;read&lt;/b&gt; and revised by members of the Gastrointestinal Research Group at Wake Forest University (SAM and VH)." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2407-2-9.anc" start="9108" end="9114" sStart="null" offset="75" sid="r9.level.n.0819" wn="1" wnkey="level%1:07:00::" annotator="cgozo" text="In the multivariate analysis, presence of lymph nodes, lower LDH levels female sex, better performance status and fewer metastatic sites were statistically predictive of longer survival (Data not shown)." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2407-2-9.anc" start="9845" end="9849" sStart="null" offset="36" sid="r10.high.j.0968" wn="1" wnkey="high%3:00:02::" annotator="brubin" text="This binding is enhanced by high concentrations of reduced folate cofactors." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2407-2-9.anc" start="12261" end="12267" sStart="null" offset="9" sid="r10.common.j.0300" wn="4" wnkey="common%5:00:00:familiar:02" annotator="brubin" text="The most common hematologic toxicity observed was grade II and III anemia in 18% and 4% of patients respectively." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2407-2-9.anc" start="910" end="917" sStart="null" offset="174" sid="r11.benefit.n.0715" wn="2" wnkey="benefit%1:07:00::" annotator="vebatchelder" text="[ 23 24 ] Protracted venous infusion (PVI) 5-FU regimens have also resulted in increased response rates in some studies, but only results in a modest benefit in median survival." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2407-2-9.anc" start="4806" end="4812" sStart="null" offset="0" sid="null" wn="1" wnkey="become%2:30:00::" annotator="carichter" text="Treatment was continued until disease progression &lt;b&gt;became&lt;/b&gt; evident or side effects &lt;b&gt;became&lt;/b&gt; intolerable." />
  </sentences>
</list>